World Kinase Inhibitors Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3773321
  • Report
  • Region: Global
  • Allied Analytics LLP
1 of 2
Protein kinase is an enzyme that shuffles protein structure by transferring phosphate collected from ATP(Adenosine Triphosphate) . Protein kinase help in regulating variety of cell functions such as cell cycle, cell differentiation, cell proliferation and apoptosis. These cell processes are used in regulating various cell activities in cancer. The global inhibitors market was valued at approximately $105 billion. Increase in incident of cancer diseases is driving the growth for kinase inhibitor market. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. This shows potential for kinase inhibitors in cancer therapies. The growth of kinase inhibitor market is hindered by cost of treatment and lack of funds in conducting research. For Example, the cost of TKI (Tyrosin kinase inhibitors) was approximately $26,400 in non-pharmaceutical spending in 2012

Increase in clinical trials for commercialization of kinase inhibitors in cancer treatment is facing challenges due to strict government regulations. However, an increase in investment from pharmaceutical companies is promoting the growth for kinase inhibitor market. This report provides an in depth analysis of clinical development and reimbursement strategies adopted by respective governments.

Key companies include in the report are Bristol-Myers Squibb, Boehringer Ingelheim, Cytrx Corporation, Eisai Inc. Eton Bioscience Inc., Glaxosmithkline, Merck Serono Sa, Novartis International Ag, Osi Pharmaceuticals Llc, Pfizer.

KEY BENEFITS

The report provides key developmental strategies adopted by top market players engaged in this business so that companies involved in development kinase inhibitors market can get competitive intelligence of their competitors
The report focuses on market estimation for types of kinase inhibitors and geographic segments are derived from current market scenario and expected market trends that are forecasted
Competitive landscape and competitor strategy analysis would help in better planning and execution of business strategies
SWOT analysis and strategic developments included in the report for key market players are included in the report to get better understanding of potential opportunities and challenges for companies
Impact analysis of top 10 factors to provide market situation to top management of surgical equipment market.

KEY MARKET SEGMENTS

BY TYPES

Tyrosin kinase inhibitors (TKI)
Receptor Tyrosine Kinase Inhibitors

EGFR
PDGFR
VEGFR
HER2

Non-Receptor Tyrosine Kinase Inhibitors

BCR-ABL
Janus Kinase (JAK) Inhibitor
Mesenchymal Epithelial Transition Growth Factor (c-MET)
Spleen Tyrosine Kinase (SYK) Inhibitors

Mulikinase inhibitors
Threonine kinase inhibitor
mTOR Kinase Inhibitors
B RAF
RHO Kinase Inhibitors
Cyclin Dependant Kinase Inhibitor
Aurora Kinase Inhibitors
MAP/MEK Kinase Inhibitors
JNK Inhibitors
Protein Kinase C Inhibitors
PI3K Inhibitors
Others (Monoclonal antibody kinase inhibitor)
Humanized monoclonal antibody
Chimeric monoclonal antibody
Human monoclonal antibody

BY GEOGRAPHY

North America
Europe
Asia-Pacific
RoW

KEY AUDIENCES

Pharmaceutical companies
Private and Government research institutes
Academic Institutes
Healthcare facilities



* This report will be delivered in 12 Business Days. *
READ MORE
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
Note: Product cover images may vary from those shown
Adroll
adroll